vimarsana.com

Latest Breaking News On - Nancy van osselaer - Page 1 : vimarsana.com

Molecure reports continued pipeline momentum for 6 months ended 30th June 2022

Our new name "Molecure" reflects expansion of scope of small molecule targets from novel proteins to mRNA in discovery & development of breakthrough therapies.

United statesEleanor perkinFrazer hallMarcin szumowskiMarta borkowskaNancy van osselaerSamson fungAgnieszka rajczuk szczepaSandi greenwoodYale universityFlemish institute for biotechnologyWarsaw stock exchangeCompany youtubeInternational institute of molecularUniversity of michiganRutgers university

OncoArendi Therapeutics Reports Continued Strategic and Operational Momentum for 12 Months ended 31 December 2021

- Significant partnership agreement with the world-renowned International Institute of Molecular and Cell Biology in Warsaw (IIMCB) to accelerate the strategic development of OncoArendi's small

United statesEleanor perkinFrazer hallMarcin szumowskiAgnieszka rajczuk szczepanskaSamson fungRafal kaminskiNancy van osselaerAdam golebiowskiZbigniew zaslonaSandi greenwoodMagdalena lickaWarsaw stock exchangeInternational institute of molecularUniversity of michiganInternational institute

OncoArendi Therapeutics supervisory board welcomes international biopharmaceutical experts: Nancy Van Osselaer, Paul van der Horst and Rafal Kamiński as its new members

/PRNewswire/ OncoArendi Therapeutics S.A. ("OncoArendi"; WSE: OAT), a clinical stage biotechnology company that uses its world leading medicinal.

Zuid hollandEleanor perkinFrazer hallMarcin szumowskiRafal kamiVan osselaerNancy van osselaerAngelini pharmaSandi greenwoodMagdalena lickaErasmus university medical centre in rotterdamGilead sciencesCompany scientificNational institute of healthAngelini industriesKempen co

OncoArendi Therapeutics supervisory board welcomes international biopharmaceutical experts: Nancy Van Osselaer, Paul van der Horst and Rafal Kamiński as its new members

/PRNewswire/ OncoArendi Therapeutics S.A. ("OncoArendi"; WSE: OAT), a clinical stage biotechnology company that uses its world leading medicinal.

Zuid hollandEleanor perkinFrazer hallMarcin szumowskiRafal kamiVan osselaerNancy van osselaerAngelini pharmaSandi greenwoodMagdalena lickaErasmus university medical centre in rotterdamGilead sciencesCompany scientificNational institute of healthAngelini industriesKempen co

vimarsana © 2020. All Rights Reserved.